GSK plc GSK announced that the FDA has accepted its regulatory filing seeking to expand the use of its RSV vaccine, Arexvy, in adults under 50 who are at a higher risk of the disease. A final decision ...

GSK has applied to the US Food and Drug Administration (FDA) to extend use of its respiratory syncytial virus (RSV) vaccine Arexvy to adults under the age of 50 who are at increased risk of the ...

If approved in the world's biggest pharmaceuticals market, GSK's vaccine, Arexvy, would be competing for a market share in ...

As many as 20 people developed a potentially paralysing illness after getting the respiratory syncytial virus (RSV) vaccine.

British regulators issued the alert for two versions of a jab given to millions of pensioners and pregnant women after ...

The UK drug watchdog has issued an alert to the NHS after the RSV jab was linked to a rare condition that needs "urgent ...

The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...

NIS 2.5 million class action lawsuit filed against El Al for failing to automatically reassign passengers to emergency flights at no cost, leaving customers stranded and forced to repurchase tickets.

Israel National News Global News The dark secret of Britain's new MI6 chief The dark secret of Britain's new MI6 chief Blaise Metreweli, set to lead British intelligence in October, revealed as ...

Kinlochewe Primary in Wester Ross has been mothballed since 2022 because of low pupil numbers.